Future Science Group
Browse
1/1
10 files

Supplementary Tables – Clinical effectiveness outcomes and healthcare resource utilization of patients diagnosed with small-cell lung cancer

dataset
posted on 2022-06-17, 07:29 authored by Figshare Future Science GroupFigshare Future Science Group, Junji Lin, Santosh Gautam, Nan Hu, Gboyega Adeboyeje, Sumesh Kachroo

  

Supplemental Table 1. Summary of Treatment Distribution for Patients with eSCLC by Regimen-based Line for 1L, 2L, and 3L

  

Supplemental Table 2. Treatment Regimen Distribution for Patients with eSCLC by Regimen-Based Line of Treatment for 1L, 2L, and 3L

  

Supplemental Table 3. Healthcare Resource Utilization by Performance Status for 1L Therapy

  

Supplemental Table 4. Mixed Model for General Physical Symptoms

  

Supplemental Table 5. Mixed Model for Treatment Side Effects

  

Supplemental Table 6. Mixed Model for Acute Distress

  

Supplemental Table 7. Mixed Model for Despair

  

Supplemental Table 8. Mixed Model for Impaired Ambulation

  

Supplemental Table 9. Mixed Model for Impaired Performance

  

Supplemental Table 10. Demographic Characteristics, Clinical Characteristics, and Comorbidities of Patients with eSCLC by Systemic Treatment

History